Share Name Share Symbol Market Type Share ISIN Share Description
Indivior LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.60p +0.16% 369.40p 369.30p 369.50p 370.20p 365.00p 366.40p 2,001,352.00 16:15:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 688.2 193.4 21.7 14.4 2,691.37

Indivior Share Discussion Threads

Showing 201 to 224 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
21/2/2017
09:06
I suppose tomorrow we can look forward to the normal rollercoaster ride.Fasten your safety belts.
steeplejack
17/2/2017
11:06
Yes, this thing has been building up nicely ahead of the figures, due next Wednesday 22 Feb. The actual run of late has been quite impressive. Next week may reveal ! A couple of times in the past the stock has gone into a reversal within a few days after the figures but really I find this stock difficult to read. Having said that, I believe in the medium/long term. I had expected to be overseas on the day of the figures but a change of plan means that on the day I can tune into the investor briefing.
gregmorg
17/2/2017
10:28
All time high.
steeplejack
07/2/2017
16:47
This thing is looking perky for near term reasons I cannot fathom. I did swap a couple of the vein things into this one as a bit of a top up two months or so ago but felt I was purely fiddling. Balanced the holdings up a bit so we shall see which one wins out, I Suspect indivior wins but why this move now is beyond me !
gregmorg
03/2/2017
14:52
Whether true or not, this change in FD seems to be orderly succession planning with Cary having carried out his tasks thru assisting Indivior to find its feet as an independent public company. So the former FD of the Reckitt Pharma subsidiary changes title and becomes the new FD of the enhanced former Reckitt pharma subsidiary. On the face of it -fair enough!
gregmorg
03/2/2017
10:39
Market seems a bit more positive than Cantor. Any day now we should get RNS official advice of results due on 22 Feb. Bit surprised we haven't heard much over the last couple of months re the outstanding legal issues . No doubt all will be revealed in time. Getting nearer to the next phase of product news.
gregmorg
03/2/2017
08:22
note on Indivior PlcCantor Fitzgerald today reaffirms its hold investment rating on Indivior Plc (LON:INDV) and set its price target at 300p.Story provided by StockMarketWire.com
steeplejack
09/1/2017
14:59
Yes,it reads well.
steeplejack
09/1/2017
13:39
Just read the various PDF slides to be used accompanying the JP Morgan Conference to be held in 2 days time. Bit strange its published two days beforehand but I am not complaining! All stills seems up quite upbeat. Answers on the litigation not discernible to me but I guess some progress being made. Market seems to like it. Re the stated revenue upgraded projection, I am not sure whether this is just a restatement from the last quarterly statement or not-- but am assuming so.
gregmorg
17/12/2016
15:18
Jeffries was the upgrade on 16 Dec....target price now 440p,BUY
steeplejack
16/12/2016
09:37
Not sure who has updated today but here's a list of latest forecasts.Yesterday was a tree shake then.Could make one rather cynical.Closing price Old price target New price target Broker change12-Dec-16 Deutsche Buy 289.60p - 395.00p Reiteration15-Nov-16 Deutsche Buy 346.90p - 400.00p Reiteration07-Nov-16 Jefferies Buy 352.40p 370.00p 450.00p Reiteration03-Nov-16 Deutsche Buy 369.00p 395.00p 400.00p Reiteration03-Nov-16 numis Buy 369.00p - 450.00p Reiteration26-Oct-16 numis Buy 314.50p - 370.00p Reiteration22-Aug-16 Jefferies Buy 320.30p 330.00p 370.00p Reiteration17-Aug-16 numis Buy 327.40p - 370.00p Reiteration09-Aug-16 RBC Capital Markets Sector perform 298.30p 185.00p 325.00p Reiteration26-Jul-16 Jefferies Buy 272.20p 285.00p 320.00p Reiteration19-Jul-16 Citigroup Neutral 268.90p - 280.00p DownGrade29-Jun-16 Jefferies Buy 239.50p
steeplejack
16/12/2016
08:22
lovely upgrade today buy PT 4.80
bigboots
15/12/2016
09:31
Litigation news?
steeplejack
15/12/2016
09:28
Bit of volume coming thru, is there news out there, cant see anything on the wires...
bigboots
15/12/2016
09:21
Someone thinks they have a story but since the stock is now well over a pound or some 30% off the years high,I guess I can only conclude I've missed the boat.Things are pretty feral at the moment and pre Trump,it appears easy to knock the stuffing out of a stock with little more than a Twitter.A perversely brave new world dominated by computer trading and spurious rumour.
steeplejack
14/12/2016
12:48
Will bear with it, as always, but the current malaise is becoming tedious. Mind you that's the current experience with similar stocks. They appear to react positively to good news but not much else and not for long!
gregmorg
08/12/2016
08:40
I think the CMA decision to fine Pfizer over the pricing of its anti epilepsy drug had a wash through effect here.Natter about unfair pricing,compromising generic competition etc,all potentially very relevant re anti trust allegations surrounding Suboxone.Time will tell.There's a witch hunt going on.
steeplejack
07/12/2016
18:06
Could well be right! I note the property market has escaped the Trump affect so far. Could I assume that he will pronounce adversely on that at some stage!!
gregmorg
07/12/2016
17:35
From aircraft to refrigeration and drug manufacturers,Mr Trump has a view on all things.I think with litigation in the wings,the price fall today was reactive rather than predictive but that's a guess of course.The drug stocks have lost their mojo in a market that fairly slavishly follows bonds in feeling that US growth and inflation are on the horizon.Many slip between cup and lip.
steeplejack
07/12/2016
17:24
Mm, Volume surprisingly high here. The R and D day is on the 9th December and starts at 7.30 am NY time . Obviously someone somewhere either knows or wants us to believe they know something. We are awaiting a further legal ruling on the various patent cases but this is actually a tad behind the envisaged schedule. Maybe Mr Trump has panicked a holder but I will sit and wait for news. Over the years in many/most stocks its worked for me.
gregmorg
07/12/2016
16:37
Trump's twitters have weakened sentiment towards drug stocks with talk of imposing drug price cuts.He's going to be a busy little bee when he takes office.He makes for a feral equity market with his unencrypted comments.
steeplejack
09/11/2016
08:52
And up go all the drug stocks on the Trump victory.Back in the 1990s ,I went to a Smithkline Beecham meeting.At the front of the hall was a photo of Hilary Clinton."You're probably wondering why we have this photograph here", said a member of the SKB team,"it's here to remind you that this woman is NOT the President of the United States!"The dislike of Hilary Clinton is pretty universal amongst drug companies emanating from all those years ago when she attacked their practises and profitability.Today we're enjoying a relief rally that she's not in power.
steeplejack
07/11/2016
10:39
remembr though that the litigation problem remains - i wont add until this is resolved
ali47fish
07/11/2016
09:49
Thanks for the link. It provides a great read.
gregmorg
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170221 16:30:07